Not provided
Not provided
Not provided
Not provided
Due to slow recruitment the study was terminated
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tampere University Hospital | OTHER |
| Turku University Hospital | OTHER_GOV |
| Helsinki University Central Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Aim of the study is to investigate the impact of two different fractions of inspired oxygen (FiO2) on outcome in patients with severe traumatic brain injury (TBI).
The high oxygen group is treated during mechanical ventilation with either a fraction of inspired oxygen of 0.7 (high oxygen group) or a fraction of inspired oxygen 0.4 (control group). The intervention continues until withdrawal of mechanical ventilation, ICU discharge or until 14 days from ICU randomisation.
Primary outcome is worse than expected outcome in the corresponding treatment arms based on outcome meas-ured by the probability of bad outcome using the CRASH® risk calculator (prognostic model for predicting outcome after traumatic brain injury).
Secondary outcome is occurence of lung injury during mechanical ventilation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fraction of inspired oxygen of 0.4 | Active Comparator | Fraction of inspired normobaric oxygen of 0.4 (low oxygen group) |
|
| Fraction of inspired oxygen of 0.7 | Active Comparator | Fraction of inspired normobaric oxygen of 0.7 (high oxygen group) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Normobaric oxygen | Other | Fraction of inspired oxygen |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glasgow outcome scale(GOS) and/or Extended glasgow outcome scale (GOSE) | The study is powered to have 80% power at 5% significance level to detect a treatment effect that decreases the proportion of poor outcome from 55% to 45%. Each patient is given an individualized tailored prognosis based on patient's baseline prognosis in a large reference population. Outcome is measured by using functional outcome score, Glasgow outcome score (GOS) and/or GOS extended (GOSE). | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| 6 month outcome | Combined proportion of unfavourable neurological outcomes at 6 months: severe disability (GOSE 2-4) or death (GOSE 1): Occurence of lung injury during mechanical ventilation: ALI-criteria or ARDS criteria used (paO2/FiO2 ratio less than 300 or 200 respectively): Mortality at 6 months: Proportion of surviving patients with unfavourable neurological outcome at 6 months (GOSE 2-4). Quality of life assessment (EQ-5D) at 6 months: Prolonged mechanical ventilation Re-intubation rates |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Esko Ruokonen, Professor | Kuopio University Hospital | Principal Investigator |
| Stepani J Bendel, MD,PhD | Kuopio University Hospital | Study Director |
| Maarit Lång, MD | Kuopio University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Helsinki University Central Hospital, Töölö Hospital | Helsinki | Töölö | 00029 | Finland | ||
| Kuopio University Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Kuopio |
| 70211 |
| Finland |
| Tampere University Hospital | Tampere | 33521 | Finland |
| Turku University Hospital | Turku | 20521 | Finland |